Kidney and hypertension

被引:2
作者
Quack, I. [1 ]
Rump, L. C. [1 ]
机构
[1] Univ Dusseldorf, Univ Klin, Klin Nephrol, D-40225 Dusseldorf, Germany
来源
INTERNIST | 2009年 / 50卷 / 04期
关键词
Arterial hypertension; Microalbuminuria; Chronic kidney disease; Hypertensive nephropathy; Cardiovascular risk; STAGE RENAL-DISEASE; CONVERTING-ENZYME-INHIBITOR; RENIN-ANGIOTENSIN SYSTEM; BLOOD-PRESSURE; CARDIOVASCULAR OUTCOMES; MICROANGIOPATHIC HEMOLYSIS; SYMPATHETIC OVERACTIVITY; PROTEINURIA REDUCTION; COMBINATION TREATMENT; ALDOSTERONE SYSTEM;
D O I
10.1007/s00108-008-2290-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In patients with chronic kidney disease elevated blood pressure is a common finding, but primary hypertension can also damage healthy kidneys. Renal outcome is strictly dependent on blood pressure, no matter whether the kidneys are cause or consequence of hypertension. Furthermore, hypertension and kidney disease are strong cardiovascular risk factors. In every patient diagnosed with hypertension glomerular filtration rate has to be checked. Proteinuria and structural abnormalities of the kidneys should be ruled out. Patients with a decreased glomerular filtration rate, proteinuria or pathologic ultrasound should be seen by a nephrologist. A strict antihypertensive therapy (blood pressure < 130/80 mmHg) can substantially improve the prognosis of hypertensive renal patients. In patients with kidney damage, inhibitors of the renin-angiotensin-system are preferred. To avoid adverse events a close monitoring of antihypertensive therapy is warranted.
引用
收藏
页码:410 / +
页数:10
相关论文
共 57 条
[41]   The effect of a lower target blood pressure on the progression of kidney disease: Long-term follow-up of the modification of diet in renal disease study [J].
Sarnak, MJ ;
Greene, T ;
Wang, XL ;
Beck, G ;
Kusek, JW ;
Collins, AJ ;
Levey, AS .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (05) :342-351
[42]   Calcium channel blockers and renal protection:: Insights from the latest clinical trials [J].
Segura, J ;
García-Donaire, JA ;
Ruilope, LM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 :S64-S66
[43]  
Sica D A, 2001, J Clin Hypertens (Greenwich), V3, P110, DOI 10.1111/j.1524-6175.2001.00455.x
[44]   ACE-inhibitor use and the long-term risk of renal failure in diabetes [J].
Suissa, S ;
Hutchinson, T ;
Brophy, JM ;
Kezouh, A .
KIDNEY INTERNATIONAL, 2006, 69 (05) :913-919
[45]  
Svensson P, 2001, HYPERTENSION, V38, pE28, DOI 10.1161/hy1101.099502
[46]   Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: An open-label crossover randomized controlled trial [J].
Tylicki, Leszek ;
Rutkowski, Przemyslaw ;
Renke, Marcin ;
Larczynski, Wojciech ;
Aleksandrowicz, Ewa ;
Lysiak-Szydlowska, Wieslawa ;
Rutkowski, Boleslaw .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 52 (03) :486-493
[47]   The renin-angiotensin system in malignant hypertension revisited: Plasma renin activity, Microangiopathic hemolysis, and renal failure in malignant hypertension [J].
van den Born, Bert-Jan H. ;
Koopmans, Richard P. ;
van Montfrans, Gert A. .
AMERICAN JOURNAL OF HYPERTENSION, 2007, 20 (08) :900-906
[48]   Microangiopathic hemolysis and renal failure in malignant hypertension [J].
van den Born, BJH ;
Honnebier, UPF ;
Koopmans, RP ;
van Montfrans, GA .
HYPERTENSION, 2005, 45 (02) :246-251
[49]   Hypertension in patients with renal artery stenosis [J].
Voiculescu, A. ;
Rump, L. C. .
INTERNIST, 2009, 50 (01) :42-+
[50]  
Volhard F, 1914, BRIGHTSCHE NIEREN KR